60 DEGREES PHARMACEUTICALS, INC. Federal State And Local Income Tax Expense Benefit Continuing Operations
60 DEGREES PHARMACEUTICALS, INC. (SXTP) reported Federal State And Local Income Tax Expense Benefit Continuing Operations of $0 for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations · last filed 2025-08-13
- 60 DEGREES PHARMACEUTICALS, INC. federal state and local income tax expense benefit continuing operations for the quarter ending 2025-06-30 was $0.00.
- 60 DEGREES PHARMACEUTICALS, INC. federal state and local income tax expense benefit continuing operations for the quarter ending 2024-06-30 was $0.00.
| Period end | Federal State And Local Income Tax Expense Benefit Continuing Operations 3 month | Federal State And Local Income Tax Expense Benefit Continuing Operations 6 month |
|---|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |